{"id":"NCT04360187","sponsor":"Pfizer","briefTitle":"Crisaborole for Chinese and Japanese Subjects (â‰¥2 Years of Age) With Mild to Moderate Atopic Dermatitis","officialTitle":"A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE BLIND, VEHICLE CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF CRISABOROLE OINTMENT, 2% IN CHINESE AND JAPANESE PEDIATRIC AND ADULT SUBJECTS (AGES 2 YEARS AND OLDER) WITH MILD TO MODERATE ATOPIC DERMATITIS","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-07-27","primaryCompletion":"2021-09-08","completion":"2021-09-08","firstPosted":"2020-04-24","resultsPosted":"2022-05-02","lastUpdate":"2022-06-07"},"enrollment":391,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Atopic Dermatitis"],"interventions":[{"type":"DRUG","name":"Crisaborole Ointment","otherNames":[]},{"type":"DRUG","name":"Crisaborole Placebo Vehicle","otherNames":[]}],"arms":[{"label":"Crisaborole ointment","type":"EXPERIMENTAL"},{"label":"Crisaborole Placebo Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"This study is a phase 3, randomized, double blind and vehicle study to evaluate the efficacy and safety of Crisaborole ointment, 2% in Chinese and Japanese subjects with mild to moderate atopic dermatitis involving at least 5% treatable BSA. Eligible subjects will be randomized in a 2:1 ratio to one of 2 treatment groups (Crisaborole BID, Vehicle BID, respectively).","primaryOutcome":{"measure":"Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Day 29","timeFrame":"Baseline, Day 29","effectByArm":[{"arm":"Vehicle Twice a Day (BID)","deltaMin":-42.79,"sd":null},{"arm":"Crisaborole 2% Twice a Day (BID)","deltaMin":-59.92,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0002"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":2},"locations":{"siteCount":39,"countries":["China","Japan","South Korea"]},"refs":{"pmids":["38748345"],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=C3291032"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":131},"commonTop":["Application site pain","Dermatitis atopic","Folliculitis","Nasopharyngitis","Upper respiratory tract infection"]}}